<DOC>
	<DOCNO>NCT00144547</DOCNO>
	<brief_summary>This open-label , extension , Phase III study evaluate long-term safety efficacy MRA patient RA participate Study MRA012JP .</brief_summary>
	<brief_title>Long-term Treatment Study MRA Rheumatoid Arthritis ( RA ) From Study MRA012JP</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Inclusion criterion Patients must suffer RA , must participate precede study . Patients must confirm appropriate week 52 preceding study X radiography . Exclusion criteria Patients evaluate belong Steinbrocker 's class IV within 4 week administration study drug Patients register 3 month week 52 preceding study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>